With $138M grant from Lilly Endowment, IU launches initiative to accelerate bioscience innovation

2025-01-04T13:28:27-05:00December 12, 2024|

IU News Press Release: https://news.iu.edu/live/news/43205-with-138m-grant-from-lilly-endowment-iu-launches Funding will support IU LAB, a state-of-the-art facility at 16 Tech harnessing Indiana’s extensive resources to become national leader in bioscience discovery, commercialization, talent development INDIANAPOLIS — Indiana University will lead significant advances in human health and help make Indiana a global leader in bioscience innovation by establishing the IU Launch Accelerator for Biosciences, known as IU LAB, at the 16 Tech Innovation District in Indianapolis. The first-of-its-kind academic-industry initiative is supported by a $138 million Lilly Endowment Inc. grant to the IU Foundation — IU’s largest grant ever in support of research and development. In collaboration with some of the state’s key biosciences organizations — including IU, IU School of Medicine, 16 Tech, Central Indiana Corporate Partnership, BioCrossroads, Indiana Biosciences Research Institute, Regenstrief Institute and IU Health — IU LAB will drive advancements [...]

Central Indiana Corporate Partnership announces senior leadership appointments across BioCrossroads, Conexus Indiana and TechPoint

2024-12-19T00:27:36-05:00December 12, 2024|

INDIANAPOLIS – The Central Indiana Corporate Partnership (CICP), alongside its branded initiatives BioCrossroads, Conexus Indiana and TechPoint, today announces the appointment of three senior leaders who will play pivotal roles in shaping the future of Indiana’s life sciences, advanced manufacturing and logistics and technology sectors. Douglas Kiehl, Patrick “PJ” McGrew and Casey Osterkamp joined BioCrossroads, Conexus Indiana and TechPoint, respectively, in senior leadership roles on December 10. “As we ensure the strength of Indiana’s advanced industries, these strategic hires underscore our commitment to building a thriving, innovative economy,” said Melina Kennedy, CEO of the Central Indiana Corporate Partnership. “Doug, PJ and Casey each bring a depth of expertise that will help us tackle workforce challenges, advance technological adoption and foster cross-sector collaboration. Together, they will elevate our efforts to position Indiana as a global leader in innovation and talent [...]

Over $1 million in grants to start building new apprenticeship pathway

2025-01-07T11:48:01-05:00November 12, 2024|

Grants from the Fairbanks Foundation to fund formation of industry “talent associations” as critical step for new pathway’s goal of welcoming students as early as 2025-2026 school year INDIANAPOLIS – A new professional education and training pathway for Hoosiers rooted in a youth apprenticeship experience starting in high school is one step closer to reality. Today, the Richard M. Fairbanks Foundation announced over $1 million in grants to fund the next steps of the CEMETS iLab Indiana strategic plan to build a new path that could welcome students in at least one occupation as early as the 2025-2026 school year. The Fairbanks Foundation is awarding grants to two Indiana organizations to launch industry “talent associations,” which are organizations that enable employers within their industry to speak with one voice when it comes to their talent needs. The talent associations will [...]

BioCrossroads announces the 2024 Indiana Life Sciences Summit, “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management”

2024-09-12T10:55:22-04:00July 16, 2024|

FOR IMMEDIATE RELEASE INDIANAPOLIS – BioCrossroads is excited to announce the annual Indiana Life Sciences Summit, scheduled for November 7, 2024, at the Biltwell Event Center in Indianapolis. The Summit will focus on "Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” highlighting Indiana's significant impact on healthcare, particularly in the development of GLP-1 therapies, which are revolutionizing diabetes and obesity care, and the opportunities that lie ahead for continued advancement of future therapies. GLP-1 therapies, developed and delivered through the relentless efforts of Indiana's researchers and companies, have emerged as vital tools in managing obesity and diabetes, offering new hope to millions worldwide. Nationwide, more than 38 million (1) Americans are living with diabetes, with obesity being linked to as many as 53 percent of new cases of type 2 diabetes each year (2). In Indiana, more [...]

Indiana solidifies leadership in Life Sciences with remarkable growth in 2023

2024-05-08T11:33:04-04:00May 6, 2024|

With a $95 billion economic contribution and significant advancements over the past year, Indiana solidifies its position as a global leader in life sciences. INDIANAPOLIS — In a year marked by incredible accomplishments, Indiana's life sciences industry once again demonstrated its capacity for substantial economic contribution and pioneering innovation, successfully securing $5.5 billion in capital investment in 2023, despite global economic challenges. This funding underscores the state's resilience and commitment to maintaining a thriving life sciences sector, which contributed $95 billion to Indiana’s economy last year alone. The breakdown of the 2023 investments is as follows: $8.2 million in SBIR/STTR funding awarded to 17 companies, $287.5 million in Venture Capital invested in 34 companies, $160.7 million accessed through public markets by three companies, Nearly $3.5 billion in mergers and acquisitions related to Indiana life sciences companies, $1.5 billion in capital [...]

WISH-TV: BioCrossroads is working to grow life sciences in Indiana

2024-04-15T12:05:47-04:00April 15, 2024|

BioCrossroads President and CEO Vince Wong was recently featured on WISH-TV's Business, Equity and Opportunities show with Scott Sander to talk about the growth of the life sciences in Indiana. Indiana is ranked first in the nation for pharmaceutical exports and second in the nation for life sciences exports. Indiana's life sciences sector: $95B annual economic contribution 67,000+ workers 3,000+ life sciences establishments $108,000+ average wage Wong talks about an area of growth for the sector including attracting companies that manufacture devices to treat and manage diseases. He also talks about the need to continue to attract talent into the growing sector. WATCH (Sources: WISH-TV and BioCrossroads)

IIB: New BioCrossroads CEO bullish on Indiana’s life sciences future

2024-03-15T11:54:38-04:00February 5, 2024|

In February, BioCrossroads, the life sciences initiative of CICP, announced Vince Wong as its new President and CEO. Wong said his experience with both a major corporation and a small startup will prove valuable for his new role. Wong discussed how his previous work will benefit his new job and the state in an interview with Inside INdiana Business, Business of Health Reporter Kylie Veleta. READ MORE (Sources: Inside INdiana Business, BioCrossroads)

BioCrossroads Welcomes Vince Wong as President and CEO

2024-01-31T09:05:19-05:00January 31, 2024|

In a pivotal moment for Indiana’s life sciences sector, Vince will play a crucial role in championing the newly released life sciences industry strategy. INDIANAPOLIS — Following a thorough national search, BioCrossroads, a catalyst for Indiana's life sciences sector, today announced the appointment of Vince Wong as its new president and CEO. An esteemed leader with a rich background in healthcare and life sciences, Vince takes the helm at BioCrossroads ready to harness his vast expertise to elevate the organization’s impact on Indiana’s life sciences ecosystem. Vince’s extensive experience at both multinational and venture backed start-up life science companies, coupled with deep-rooted insights into the life sciences sector, both locally and nationally, position him as a visionary leader who will help drive the recently released life sciences strategy for Indiana. Read the report: TEConomy Partners: A Strategic Roadmap for Advancing [...]

Igniting an Industry: A Strategic Vision for Indiana’s Future as a Global Leader in Life Sciences

2024-01-09T00:42:32-05:00January 8, 2024|

Collaborative efforts in four key areas will establish Indiana as the leading state for advancing innovations into products that improve health and well-being INDIANAPOLIS – Marking a significant milestone since Indiana’s designation as a federal Tech Hub in October 2023, BioCrossroads today unveils a groundbreaking strategic framework poised to catapult Indiana to the forefront of the global life sciences sector. This comprehensive industry strategy, crafted in collaboration with TEConomy Partners, is set to transform Indiana’s life sciences landscape, focusing on four pivotal areas: Fostering research and development and innovation Enhancing the state’s life sciences manufacturing ecosystem Boosting Indiana’s life sciences talent and workforce Supporting connections and outreach across the sector This strategy is set to transform Indiana’s life sciences sector through the development of strategic manufacturing hubs and targeted investments that enhance the state's domestic manufacturing capabilities. These efforts are [...]

Go to Top